Challenges and New Momentumchina’s pharmaceutical innovation goes global challenges and new momentumIn the first five months ...

The Eurofins (Paris:ERF) network of companies delivered steady improvement in organic revenue growth during the first nine ...

Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025 VIENNA, ...

October 21, 2025 - Nanoform Finland Plc (“Nanoform”), a leading nanoparticle medicine performance-enhancing company, today announced that key findings from two proof-of-concept studies conducted in ...

Funds build on close to €30M in legacy support to advance Exeliom’s immunomodulator program, EXL01, addressing cancers, inflammatory and infectious diseases Paris, France, October 21, 2025 — Exeliom ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...

H. Lundbeck A/S (Lundbeck) and Contera Pharma today announced a strategic research collaboration aiming to accelerate the discovery and development of innovative oligonucleotide-based medicines for ...

Recommendation based on TULIP-SC Phase III trial results showing first-in-class Saphnelo reduced disease activity via once-weekly subcutaneous administration AstraZeneca's Saphnelo (anifrolumab) has ...

Adaptyx Biosciences announced today it has raised $14 million in seed financing, bringing total funding to $23 million since inception. The round was led by Interlagos, with significant participation ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today welcomed a new £6 million investment by GSK plc (LSE/NYSE: GSK) and ViiV Healthcare, the global specialist HIV company ...

DKSH Cambodia partnered with Sihanouk Hospital Center of Hope to provide 150 free breast cancer screenings for women from low-income communities, reinforcing its commitment to advancing equity in ...

Results from a US multicenter study presented at CHEST show e-Lung could have sped up Progressive Pulmonary Fibrosis (PPF) diagnosis by up to 21 monthsCHICAGO, USA and OXFORD, UK October 20th 2025 – ...